Search for Clinical Trial Results

Sponsored By

Antiphospholipid Syndrome - 32 Studies Found

Status Study
Active, not recruiting Study Name: Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody Syndrome
Condition:
  • Antiphospholipid Antibody Syndrome
  • End Stage Renal Disease

    • Date: 2009-12-09
    Interventions: Drug: Eculizumab Eculizumab will be administered by intravenous infusion. Eculizumab will be administere
Terminated Study Name: Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
Condition: Antiphospholipid Syndrome
Date: 2013-02-03
Interventions: Drug: Hydroxychloroquine Other Name: plaquenil
Completed Study Name: Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
Condition: Antiphospholipid (aPL)-Positive
Date: 2014-04-29
Interventions: Biological: Study Drug- ALXN1007 10 mg/kg IV q 2 weeks x 12 doses
Completed Study Name: CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen
Condition: Antiphospholipid Antibody Syndrome
Date: 2009-09-24
Interventions:
  • Drug: Celecoxib celecoxib 200m
Completed Study Name: Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome
Condition:
  • Systemic Lupus Erythematosus
  • Antiphospholipid Antibody Syndrome
    Date: 2001-02-02
    Interventions:
    • Drug: Cyclophosphamide
    • Drug: filgrastim
Completed Study Name: Antiphospholipid Antibodies and Early Severe Preeclampsia.
Condition:
  • Severe Preeclampsia
  • Antiphospholipid Syndrome

Date: 2012-02-19
Completed Study Name: Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
Condition:
  • Antiphospholipid Syndrome
  • Thrombophilia Due to Antiphospholipid
    Date: 2011-11-14
    Interventions: Other: Phlebotomy Subjects will have blood drawn at each of the 3 study visits.
Completed Study Name: Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)
Condition: Venous Thrombosis
Date: 2016-09-02
Interventions: Other: Blood sample
Completed Study Name: IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Condition:
  • High Risk Pregnancy
  • Pregnancy Complications
  • Atrial Fibrillation
  • Deep Vein Thrombosis
  • Cardiac Valvular
    Date: 2011-03-17
<<< Previous | Next >>>